Terms: = Sarcomas AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15 AND Treatment
7 results:
1. A case of nonleukemic myeloid sarcoma with fip1l1-PDGFRA rearrangement: an unusual presentation of a rare disease.
Chen D; Bachanova V; Ketterling RP; Begna KH; Hanson CA; Viswanatha DS
Am J Surg Pathol; 2013 Jan; 37(1):147-51. PubMed ID: 23232855
[TBL] [Abstract] [Full Text] [Related]
2. Complete response of myeloid sarcoma with fip1l1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
Tang TC; Chang H; Chuang WY
Acta Haematol; 2012; 128(2):83-7. PubMed ID: 22722648
[TBL] [Abstract] [Full Text] [Related]
3. Successful treatment of mast cell sarcoma of the uterus with imatinib.
Ma HB; Xu X; Liu WP; Chang H; Zeng F; Wang YC
Int J Hematol; 2011 Nov; 94(5):491-4. PubMed ID: 22020400
[TBL] [Abstract] [Full Text] [Related]
4. [Chronic eosinophilic leukemia with complex karyotypic abnormalities including trisomy 8].
Wakabayashi S; Yamamoto K; Arai A; Miura O
Rinsho Ketsueki; 2008 Jul; 49(7):510-5. PubMed ID: 18709984
[TBL] [Abstract] [Full Text] [Related]
5. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract] [Full Text] [Related]
6. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
Scheinfeld N
J Drugs Dermatol; 2006 Feb; 5(2):117-22. PubMed ID: 16485879
[TBL] [Abstract] [Full Text] [Related]
